Back to Search Start Over

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration

Authors :
Rupangi C. Vasavada
Juan Carlos Alvarez-Perez
Cem Demirci
Francisco Rausell-Palamos
Gabriella P. Casinelli
José Manuel Mellado-Gil
Adolfo Garcia-Ocaña
Sara Ernst
National Institutes of Health (US)
Juvenile Diabetes Research Foundation International
Pediatric Endocrine Society (US)
Source :
Diabetes, Digital.CSIC. Repositorio Institucional del CSIC, instname
Publication Year :
2013
Publisher :
American Diabetes Association, 2013.

Abstract

Hepatocyte growth factor (HGF) is a mitogen required for β-cell replication during pregnancy. To determine whether HGF/c-Met signaling is required for β-cell regeneration, we characterized mice with pancreatic deletion of the HGF receptor, c-Met (PancMet KO mice), in two models of reduced β-cell mass and regeneration: multiple low-dose streptozotocin (MLDS) and partial pancreatectomy (Ppx). We also analyzed whether HGF administration could accelerate β-cell regeneration in wild-type (WT) mice after Ppx. Mouse islets obtained 7 days post-Ppx displayed significantly increased c-Met, suggesting a potential role for HGF/c-Met in β-cell proliferation in situations of reduced β-cell mass. Indeed, adult PancMet KO mice displayed markedly reduced β-cell replication compared with WT mice 7 days post-Ppx. Similarly, β-cell proliferation was decreased in PancMet KO mice in the MLDS mouse model. The decrease in β-cell proliferation post-Ppx correlated with a striking decrease in D-cyclin levels. Importantly, PancMet KO mice showed significantly diminished β-cell mass, decreased glucose tolerance, and impaired insulin secretion compared with WT mice 28 days post-Ppx. Conversely, HGF administration in WT Ppx mice further accelerated β-cell regeneration. These results indicate that HGF/c-Met signaling is critical for β-cell proliferation in situations of diminished β-cell mass and suggest that activation of this pathway can enhance β-cell regeneration. © 2014 by the American Diabetes Association.<br />This work was supported in part by grants from the National Institutes of Health (DK-067351 and DK-077096) and the Juvenile Diabetes Research Foundation (1-2007-3) to A.G.-O. S.E. was the recipient of a postdoctoral fellowship from the National Institutes of Health T32 Research Training grant (T32DK-07052-32). C.D. was the recipient of a research fellowship from the Lawson Wilkins Pediatric Endocrine Society.

Details

Language :
English
ISSN :
1939327X and 00121797
Volume :
63
Issue :
1
Database :
OpenAIRE
Journal :
Diabetes
Accession number :
edsair.doi.dedup.....24b7a5146904b31aedcb10d127ae9d60